Hemcheck Sweden AB

HemCheck develops and commercializes a product concept for patient close detection of hemolysis. Hemolysis, broken red blood cells, is the most common cause when blood samples can’t be analyzed. This can be harmful to patients and cause high costs. Hemcheck's product detects hemolyzed blood samples directly when sampling, thereby contributing to improved care for patients worldwide.